# FDA Inspection 1172058 - Ayman Gaballah, M.D. - June 10, 2022

Source: https://www.keypedia.com/records/fda_inspections/ayman-gaballah-md/a892eb35-ef11-4260-97cc-33193552d535
Source feed: FDA_Inspections

> FDA Inspection 1172058 for Ayman Gaballah, M.D. on June 10, 2022. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1172058
- Company Name: Ayman Gaballah, M.D.
- Inspection Date: 2022-06-10
- Classification: No Action Indicated (NAI)
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

Company: https://www.keypedia.com/companies/ayman-gaballah-md/ff5dc453-8a26-4fe1-99f1-ee526faa04ae

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c